StockData

Yubo International Biotech Ltd (YBGJ) stock

YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.01+0.00 (0.00%)

Close on Oct 16, 2026Market cap $886.19KP/E –Yield –

Yubo International Biotech operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Yubo International Biotech's operating income for the twelve months ending Jun 30, 2026 was -$1.12M. For fiscal 2026 it was -$1.19M. The highest annual figure on record is -$29.00K in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2026Dec 31, 2025-$1.19M–
FY2025Dec 31, 2024-$1.77M–
FY2024Dec 31, 2023-$1.19M–
FY2023Dec 31, 2022-$1.21M–
FY2022Dec 31, 2021-$1.54M–
FY2020Feb 29, 2020-$29.00K–
FY2019Feb 28, 2019-$48.00K–
FY2018Feb 28, 2018-$58.00K–
FY2017Feb 28, 2017-$149.00K–
FY2016Feb 29, 2016-$63.00K–
FY2015Feb 28, 2015-$58.00K–
FY2014Feb 28, 2014-$55.00K–
FY2013Feb 28, 2013-$60.00K–
FY2012Feb 29, 2012-$47.00K–
FY2011Feb 28, 2011-$80.00K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ2 2026Jun 30, 2026-$238.86K–
Q1 FY2027CQ1 2026Mar 31, 2026-$289.27K–
Q4 FY2026CQ4 2025Dec 31, 2025-$285.47K–
Q3 FY2026CQ3 2025Sep 30, 2025-$310.13K–
Q2 FY2026CQ2 2025Jun 30, 2025-$249.70K–
Q1 FY2026CQ1 2025Mar 31, 2025-$467.30K–
Q4 FY2025CQ4 2024Dec 31, 2024-$357.30K–
Q3 FY2025CQ3 2024Sep 30, 2024-$532.76K-8394.6%
Q2 FY2025CQ2 2024Jun 30, 2024-$470.44K–
Q1 FY2025CQ1 2024Mar 31, 2024-$409.42K–
Q4 FY2024CQ4 2023Dec 31, 2023-$517.32K-599.9%
Q3 FY2024CQ3 2023Sep 30, 2023$6.42K–
Q2 FY2024CQ2 2023Jun 30, 2023-$367.28K–
Q1 FY2024CQ1 2023Mar 31, 2023-$316.53K–
Q4 FY2023CQ4 2022Dec 31, 2022$103.48K–
Q3 FY2023CQ3 2022Sep 30, 2022-$238.27K–
Q2 FY2023CQ2 2022Jun 30, 2022-$491.50K–
Q1 FY2023CQ1 2022Mar 31, 2022-$578.94K–
Q4 FY2022CQ4 2021Dec 31, 2021-$388.20K–
Q3 FY2022CQ3 2021Sep 30, 2021-$346.01K–
Q2 FY2022CQ2 2021Jun 30, 2021-$370.09K–
Q1 FY2022CQ1 2021Mar 31, 2021-$438.57K–
Q4 FY2020CQ1 2020Feb 29, 2020-$4.00K–
Q3 FY2020CQ4 2019Nov 30, 2019-$8.00K–
Q2 FY2020CQ3 2019Aug 31, 2019-$8.00K–
Q1 FY2020CQ2 2019May 31, 2019-$8.00K–
Q4 FY2019CQ1 2019Feb 28, 2019-$8.00K-200.0%
Q3 FY2019CQ4 2018Nov 30, 2018-$7.00K–
Q2 FY2019CQ3 2018Aug 31, 2018-$12.00K–
Q1 FY2019CQ2 2018May 31, 2018-$21.00K–
Q4 FY2018CQ1 2018Feb 28, 2018$8.00K–
Q3 FY2018CQ4 2017Nov 30, 2017-$22.00K–
Q2 FY2018CQ3 2017Aug 31, 2017-$22.00K–
Q1 FY2018CQ2 2017May 31, 2017-$23.00K–
Q4 FY2017CQ1 2017Feb 28, 2017-$96.00K–
Q3 FY2017CQ4 2016Nov 30, 2016-$24.00K–
Q2 FY2017CQ3 2016Aug 31, 2016-$14.00K–
Q1 FY2017CQ2 2016May 31, 2016-$16.00K–
Q4 FY2016CQ1 2016Feb 29, 2016-$13.00K–
Q3 FY2016CQ4 2015Nov 30, 2015-$14.00K–

More Yubo International Biotech figures

See a number that looks wrong?